Terms: = Head and neck cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207
3691 results:
1. [Feasibility analysis of the application of programmed process endoscopic lateral neck dissection via chest-breast approach in papillary thyroid carcinoma surgery].
Xu N; Li ZY; Luo XP; Gao HY; Huang JF; Wang YY; Liu XJ; Xu B
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1831-1836. PubMed ID: 38782751
[No Abstract] [Full Text] [Related]
2. P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/akt signaling pathway.
Wu YL; Liu W; Zhao T; Jin J
Med Oncol; 2024 May; 41(6):163. PubMed ID: 38777998
[TBL] [Abstract] [Full Text] [Related]
3. PI3K/akt Signaling Pathway Mediated Autophagy in Oral Carcinoma - A Comprehensive Review.
Rajendran P; Sekar R; Dhayasankar PS; Ali EM; Abdelsalam SA; Balaraman S; Chellappan BV; Metwally AM; Abdallah BM
Int J Med Sci; 2024; 21(6):1165-1175. PubMed ID: 38774756
[TBL] [Abstract] [Full Text] [Related]
4. Surgical outcomes of robotic thyroidectomy for thyroid tumors over 4 cm via the bilateral axillo-breast approach.
Bae HL; Wong JS; Kim SJ; Jung Y; Choi JB; Kwak J; Yu HW; Chai YJ; Choi JY; Lee KE
Sci Rep; 2024 May; 14(1):11646. PubMed ID: 38773181
[TBL] [Abstract] [Full Text] [Related]
5. DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma.
Liu Y; Sun Y; Yang J; Wu D; Yu S; Liu J; Hu T; Luo J; Zhou H
Mol Cancer; 2024 May; 23(1):104. PubMed ID: 38755637
[TBL] [Abstract] [Full Text] [Related]
6. Biomimetic bone-periosteum scaffold for spatiotemporal regulated innervated bone regeneration and therapy of osteosarcoma.
Xu Y; Xu C; Song H; Feng X; Ma L; Zhang X; Li G; Mu C; Tan L; Zhang Z; Liu Z; Luo Z; Yang C
J Nanobiotechnology; 2024 May; 22(1):250. PubMed ID: 38750519
[TBL] [Abstract] [Full Text] [Related]
7. Campothecin suppresses cell proliferation and migration in head and neck squamous cell carcinoma by blocking RAB27A-mediated phosphatidylinositol 3 kinase (PI3K)/protein kinase B (akt) pathway.
Zhao Y; Wang Y; Zhao L; Qu L; Zheng JH
J Physiol Pharmacol; 2024 Apr; 75(2):205-213. PubMed ID: 38736267
[TBL] [Abstract] [Full Text] [Related]
8. Molecular and immunological characteristics of postoperative relapse in lymph node-positive esophageal squamous cell cancer.
Pan HG; Fang HL; Zhu C; Li S; Yi H; Zhang X; Yin XY; Song YJ; Chen D; Yin CT
Cancer Med; 2024 May; 13(9):e7228. PubMed ID: 38733174
[TBL] [Abstract] [Full Text] [Related]
9. HMGA1 sensitizes esophageal squamous cell carcinoma to mTOR inhibitors through the ETS1-FKBP12 axis.
Guo JR; He KY; Yuan JL; An W; Yin WT; Li QT; Lu LY; Yang JY; Liu MJ; Li YJ; Zhao Y; Yang Q; Lei XY; Gao F; Zhang L; Wu DH; Li JQ; Zhao ZL; Liu H; Zhu LJ; Xiang XY; Sun QH; Jian YP; Xu ZX
Int J Biol Sci; 2024; 20(7):2640-2657. PubMed ID: 38725843
[TBL] [Abstract] [Full Text] [Related]
10. Chitinase 3 like-1 activates the akt pathway, inducing NF-κB-dependent release of pro-inflammatory cytokines and promoting the proliferative ability in nasopharyngeal carcinoma cells.
Li D; Fan G; Zhou Y
Cytokine; 2024 Jul; 179():156631. PubMed ID: 38710115
[TBL] [Abstract] [Full Text] [Related]
11. The involvement of epidermal growth factor receptor/protein kinase B signaling in the tumor intrinsic PD-L1-induced malignant potential of oral squamous cell carcinoma.
Sasabe E; Tomomura A; Yamamoto T
J Oral Pathol Med; 2024 May; 53(5):310-320. PubMed ID: 38693616
[TBL] [Abstract] [Full Text] [Related]
12. Fusobacterium periodonticum BCT protein targeting glucose metabolism to promote the epithelial-mesenchymal transition of esophageal cancer cells by lactic acid.
Guo X; Wan P; Shen W; Sun M; Peng Z; Liao Y; Huang Y; Liu R
J Transl Med; 2024 Apr; 22(1):401. PubMed ID: 38689341
[TBL] [Abstract] [Full Text] [Related]
13. Identification of ACAA1 and HADHB as potential prognostic biomarkers based on a novel fatty acid oxidation-related gene model in head and neck squamous cell carcinoma: A retrospective study.
Wang WL; Jiang HJ; Shen ZL; Tang YL; Jiang J; Liang XH
Arch Oral Biol; 2024 Jul; 163():105982. PubMed ID: 38678878
[TBL] [Abstract] [Full Text] [Related]
14. Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206.
Sang Y; Min R; Huang T; Zhang J
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):77-84. PubMed ID: 38678623
[TBL] [Abstract] [Full Text] [Related]
15. Differences in the response of normal oral mucosa, oral leukoplakia, oral squamous cell carcinoma-derived mesenchymal stem cells, and epithelial cells to photodynamic therapy.
Guo Q; Ji X; Zhang L; Liu X; Wang Y; Liu Z; Jin J; Han Y; Liu H
J Photochem Photobiol B; 2024 Jun; 255():112907. PubMed ID: 38677259
[TBL] [Abstract] [Full Text] [Related]
16. CircPDE5A-encoded novel regulator of the PI3K/akt pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1.
Lei K; Liang R; Liang J; Lu N; Huang J; Xu K; Tan B; Wang K; Liang Y; Wang W; Lin H; Wang M
J Exp Clin Cancer Res; 2024 Apr; 43(1):124. PubMed ID: 38658954
[TBL] [Abstract] [Full Text] [Related]
17. Annexin A2 combined with TTK accelerates esophageal cancer progression via the akt/mTOR signaling pathway.
Liu R; Lu Y; Li J; Yao W; Wu J; Chen X; Huang L; Nan D; Zhang Y; Chen W; Wang Y; Jia Y; Tang J; Liang X; Zhang H
Cell Death Dis; 2024 Apr; 15(4):291. PubMed ID: 38658569
[TBL] [Abstract] [Full Text] [Related]
18. Lactoferrin mediates epithelial-mesenchymal transformation by regulating the PI3K/akt/mTOR pathway to inhibit nasopharyngeal carcinoma metastasis.
Xu M; Fan Y; Zou G; Yang Q; Xu F
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):130-135. PubMed ID: 38650146
[TBL] [Abstract] [Full Text] [Related]
19. Squamous cell carcinoma initially occurring on the tongue dorsum: a case series report with molecular analysis.
Ono S; Hirose K; Sukegawa S; Obata K; Masui M; Hasegawa K; Fujimura A; Shimada K; Nakamura S; Teramoto A; Hori Y; Morii E; Motooka D; Igawa T; Tanaka T; Nagatsuka H; Toyosawa S; Yamamoto H
Diagn Pathol; 2024 Apr; 19(1):63. PubMed ID: 38650013
[TBL] [Abstract] [Full Text] [Related]
20. Dexrazoxane inhibits the growth of esophageal squamous cell carcinoma by attenuating SDCBP/MDA-9/syntenin-mediated EGFR-PI3K-akt pathway activation.
Du R; Xiao N; Han L; Guo K; Li K; Chen Z; Zhang H; Zhou Z; Huang Y; Zhao X; Bian H
Sci Rep; 2024 Apr; 14(1):9167. PubMed ID: 38649770
[TBL] [Abstract] [Full Text] [Related]
[Next]
